Pharm-Olam USA

Pharm-Olam established its global headquarters in Houston in 1994 and has conducted clinical trials in the USA since 2003. We have regional offices in Princeton, New Jersey and Research Triangle Park, North Carolina along with field-based CRAs through the country.

Our Houston office includes a pharmacovigilance and medical monitoring unit which supports our unit in Europe providing global coverage.

Pharm-Olam offers comprehensive services and functional outsourcing for Phase I to IV clinical research studies in the USA, including monitoring, regulatory, pharmacovigilance, data management, project management, and biostatistics.

In addition to Pharm-Olam's clinical services for commerical sponsors, we also provide services and consulting to government agencies and on government contracts.

Pharm-Olam was recognized by the State of Texas and US House of Representatives for 18 years of international clinical research.

For more information on conducting clinical trials with Pharm-Olam in the USA, please Contact Us.

Office Locations: Houston, Princeton, RTP

USA Demographics

Population: 307.2 million (82% urbanized)
Median Age: 36.7 years
Language: English, although translations in other languages may be required based on site locations.
Market: The United States has the largest pharmaceutical market in the world.

Regulatory Authorities

FDA

Clinical Trials in USA

clinicaltrials.gov Active Studies

Argentina (Buenos Aires), Belarus (Minsk), Belgium (Brussels), Brazil (São Paulo), Bulgaria (Sofia), Canada (Toronto), Croatia (Zagreb), Czech Rep. (Prague), Georgia (Tbilisi), Germany (Munich), Hungary (Budapest), India (Bangalore), Italy (Milan), Kazakhstan (Almaty), Mexico (Mexico City), Poland (Warsaw), Romania (Bucharest), Russia (Moscow, St. Petersburg, Novosibirsk), Serbia (Belgrade), Spain (Madrid), South Africa (Johannesburg), Ukraine (Kiev), United Kingdom (London), United States (Houston, Princeton, Research Triangle Park)